Ecstasy-for-Medicine Advocate Raises $100 Million

The Multidisciplinary Association for Psychedelic Studies, a nonprofit chief within the pharmaceutical psychedelics trade, has raised greater than $100 million in a Series A personal inventory sale.  

MAPS wanted the cash to fund the ultimate phases of its software for regulatory approval to promote MDMA, also referred to as Ecstasy, to deal with post-traumatic stress dysfunction, the group stated in an announcement Friday.